ARCHIVES

DCT Board Approves Drug Development Recompetition

This article is from The Cancer Letter archive.

Vol. 16 No. 46 | November 30, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: Ma and Tyner Receive Award From AAAS

July 4, 2014

Still Misperceptions On Hill About CRADA Between NCI, BMS

March 13, 1992

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.

May 20, 2005

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001